Related Experiment Videos
Treatment of hypertension in children
1Department of Pediatrics, University of Minnesota Medical School, Minneapolis 55455.
Insights
This review covers current pediatric antihypertensive therapy, emphasizing lifestyle changes and newer medications. The goal is to lower blood pressure below the 95th percentile for age and sex, avoiding rapid normalization.
Area of Science:
- Pediatric Nephrology
- Cardiology
- Pharmacology
Background:
- Current clinical practice for pediatric hypertension management has evolved since the second Task Force report.
- Non-pharmacological interventions are crucial for managing elevated blood pressure in children.
Purpose of the Study:
- To review contemporary antihypertensive therapies for children, including newer drug classes and updated clinical guidelines.
- To highlight the role of non-pharmacological strategies and current drug choices for pediatric hypertension.
Main Methods:
- Review of current literature and clinical practice guidelines regarding pediatric antihypertensive therapy.
- Focus on newer pharmacological agents and non-pharmacological interventions.
Main Results:
- Non-pharmacological therapy (weight reduction, exercise, diet) is vital for all levels of elevated blood pressure in children.
- Chronic treatment primarily involves converting enzyme inhibitors and calcium channel blockers; diuretics are for renal disease; beta-blockers have side effects; prazosin is second-line.
- Nifedipine is common for asymptomatic emergency treatment; potent IV drugs are for severe cases; rapid normalization is contraindicated.
Conclusions:
- A combination of non-pharmacological and pharmacological approaches is essential for effective pediatric hypertension management.
- Current therapeutic strategies prioritize gradual blood pressure reduction and utilize specific drug classes based on patient needs and comorbidities.
Abstract:
This review summarizes the current approach to antihypertensive therapy in children. It focuses on newer drugs, taking into account changes in clinical practice that have occurred since publication of the second Task Force report. Non-pharmacological therapy, including weight reduction, exercise, and dietary intervention, has great potential for the effective reduction of blood pressure. It should be introduced not only in patients with "significant" hypertension, but also in the care of patients with high normal blood pressure and to complement drug therapy for patients with "severe" hypertension. The goal of antihypertensive drug therapy is reduction of blood pressure to a level below the 95th percentile for age and sex. Attempts to rapidly achieve normal blood pressure immediately after starting therapy are contraindicated. The objective of emergency treatment is prevention of hypertension-related adverse events, and this usually requires only a modest reduction in blood pressure. Nifedipine has become the most commonly used drug for emergency treatment of asymptomatic children. Exceptionally severe elevations of blood pressure or the presence of symptoms should be treated with more potent intravenous drugs. The converting enzyme inhibitors and calcium channel blockers currently are the primary agents for chronic treatment of hypertension in children. Diuretics are usually reserved for hypertensive patients with renal disease. beta-Adrenergic blocking drugs also are effective but have a number of potential adverse effects. Prazosin generally is used as a second-line agent, if the above-noted drugs are ineffective. Although minoxidil is still one of the most effective antihypertensive agents, its associated adverse effects have limited its usefulness.